Fermata Advisors, LLC En V Veno Medical Corp Transaction History
Fermata Advisors, LLC
- $439 Million
- Q1 2024
A detailed history of Fermata Advisors, LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Fermata Advisors, LLC holds 23,198 shares of NVNO stock, worth $119,005. This represents 0.03% of its overall portfolio holdings.
Number of Shares
23,198
Previous 16,325
42.1%
Holding current value
$119,005
Previous $83,000
51.81%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding NVNO
# of Institutions
37Shares Held
4.05MCall Options Held
274KPut Options Held
17.8K-
Kingdon Capital Management, L.L.C. New York, NY654KShares$3.35 Million0.43% of portfolio
-
Perceptive Advisors LLC New York, NY623KShares$3.2 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA574KShares$2.94 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT496KShares$2.54 Million0.17% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$2.06 Million3.48% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $48.6M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...